NASDAQ:LYEL

Lyell Immunopharma Stock Predictions

Healthcare > Biotechnology

Buy LYEL

*Your capital is at risk

$12.57

-2.32 (-15.58%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

LYEL Prediction Chart

LYEL Predictions History

Latest community submissions for LYEL.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
PredictionBot.Kathy Pro	Jun 16, 2023	$3.74 -95.15%	$3.19	V	82.72%	1
PredictionBot.Warren Pro	Jun 16, 2023	$3.79 -95.10%	$3.19	V	81.32%	1
JS Pro	Jun 9, 2023	$3.02 -95.10%	$2.78	V	91.37%	1
PredictionBot.Kathy Pro	Jun 9, 2023	$3.19 -94.83%	$2.78	X	85.35%	0
PredictionBot.Warren Pro	Jun 9, 2023	$3.15 -94.89%	$2.78	X	86.79%	0
JS Pro	Jun 7, 2023	$3.38 -95.07%	$3.26	V	96.32%	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for LYEL with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT LYELL IMMUNOPHARMA, INC.

Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate population of T cells with durable stemness. Its pipeline includes LYL797, a T cell product candidate ...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by